Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey

Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760

Insulin resistance and cardiovascular disease

Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M., & Rubin, E. M. (2001) · Science · doi:10.1126/science.1064852 · Cited by 921

Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3

Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424 · cited 1×

The Human Obesity Gene Map: The 2005 Update

Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119

Progress and Challenges in Metabolic Syndrome in Children and Adolescents

Steinberger, J., Daniels, S. R., Eckel, R. H., Hayman, L. L., Lustig, R. H., McCrindle, B. W., & Mietus‐Snyder, M. (2009) · Circulation · doi:10.1161/circulationaha.108.191394 · Cited by 721

Pathophysiology of diabetic dyslipidaemia: where are we?

Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Fruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling

Riwanto, M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.108753 · Cited by 337

The Human Obesity Gene Map: The 2004 Update

Përusse, L., Rankinen, T., Zuberi, A. R., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G. A., Walts, B., Snyder, E. E., & Bouchard, C. (2005) · Obesity Research · doi:10.1038/oby.2005.50 · Cited by 328

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

Fruchart, J.-C., Sacks, F. M., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.046 · Cited by 260

Prevalence of Body Iron Excess in the Metabolic Syndrome

Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2061 · Cited by 224

Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans

Atzmon, G., Rincon, M., Schechter, C. B., Shuldiner, A. R., Lipton, R. B., Bergman, A., & Barzilai, N. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040113 · Cited by 222

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.

Pacifico, L., Nobili, V., Anania, C., Verdecchia, P., & Chiesa, C. (2011) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v17.i26.3082 · Cited by 201

Genetic variants and the metabolic syndrome: a systematic review

Povel, C. M., Boer, J. M. A., Reiling, E., & Feskens, E. J. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00907.x · Cited by 180

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Willems van Dijk, K., Rensen, P. C., Voshol, P. J., & Havekes, L. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00002 · Cited by 154

The risk of cardiovascular events with increased apolipoprotein CIII: a systematic review and meta-analysis

Wyler von Ballmoos, M. C., Haring, B., & Sacks, F. M. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.05.002 · Cited by 134

Council on Nutrition, Physical Activity, and Metabolism Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Hypertension, and Obesity in the Young Committee of the Council on Scientific Statement From the American Heart Association Atherosclerosis, Progress and Challenges in Metabolic Syndrome in Children and Adolescents. A

McCrindle, B. W., Mietus‐Snyder, M., Steinberger, J., Daniels, S. R., Eckel, R. H., & Hayman, L. L. (2009) · Cited by 138

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk

Lai, C., Parnell, L. D., & Ordovás, J. M. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162320.54795.68 · Cited by 137

Seaweed Lipids as Nutraceuticals

Mišurcová, L., Ambrožová, J. V., & Samek, D. (2011) · Advances in food and nutrition research · doi:10.1016/b978-0-12-387669-0.00027-2 · Cited by 126

Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population

Guettier, J.-M., Georgopoulos, A., Tsai, M. Y., Radha, V., Shanthirani, S., Deepa, R., Gross, M., Rao, G., & Mohan, V. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1338 · Cited by 108

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels

Khetarpal, S. A., Zeng, X., Millar, J. S., Vitali, C., Somasundara, A. V. H., Zanoni, P., Landro, J. A., Barucci, N., Zavadoski, W. J., Sun, Z., et al. (2017) · Nature Medicine · doi:10.1038/nm.4390 · Cited by 109

Apolipoprotein CIII-Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin-Sensitive G Protein- and Protein Kinase Cα-Mediated Nuclear Factor-κB Activation

Kawakami, A., Aikawa, M., Nitta, N., Yoshida, M., Libby, P., & Sacks, F. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000249620.68705.0d · Cited by 99

Apolipoprotein CIII links dyslipidemia with atherosclerosis

Kawakami, A., & Yoshida, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e607 · Cited by 98

Genetics of familial combined hyperlipidemia and risk of coronary heart disease

Shoulders, C. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh069 · Cited by 96

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D. C., Chen, M. M., Ooi, E. M. M., & Watts, G. F. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01678.x · Cited by 85

APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome

Miller, M., Rhyne, J., Chen, H., Beach, V., Ericson, R., Luthra, K., Dwivedi, M., & Misra, A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.013 · Cited by 89

Gamma-Glutamyl Transferase

Grundy, S. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000253905.13219.4b · Cited by 71

The −1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study

Martinelli, N., Trabetti, E., Bassi, A., Girelli, D., Friso, S., Pizzolo, F., Sandri, M. F., Malerba, G., Pignatti, P. F., Corrocher, R., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.009 · Cited by 69

Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes

Qi, L., Liu, S., Rifai, N., Hunter, D., & Hu, F. B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.006 · Cited by 67

Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation

Li, J., Li, L., Guo, D., Li, S., Zeng, Y., Liu, C., Fu, R., Huang, M., & Xie, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.029 · Cited by 67

Apolipoprotein C‐III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

Olivieri, O., Martinelli, N., Girelli, D., Pizzolo, F., Friso, S., Beltrame, F., Lotto, V., Annarumma, L., & Corrocher, R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03720.x · Cited by 63

Relative Quantitation of Glycoisoforms of Intact Apolipoprotein C3 in Human Plasma by Liquid Chromatography–High-Resolution Mass Spectrometry

Jian, W., Edom, R. W., Wang, D., Weng, N., & Zhang, S. (2013) · Analytical Chemistry · doi:10.1021/ac3034757 · Cited by 63

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome

Wu, Y., Yu, Y., Zhao, T., Wang, S., Fu, Y., Qi, Y., Yang, G., Yao, W., Su, Y., Ma, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147946 · Cited by 60

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity

Luo, M., Liu, A., Wang, S., Wang, T., Hu, D., Wu, S., & Peng, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-02601-7 · Cited by 62

Smoking Is Associated With Reduced Risk of Autoimmune Diabetes in Adults Contrasting With Increased Risk in Overweight Men With Type 2 Diabetes

Rasouli, B. S., Grill, V., Midthjell, K., Ahlbom, A., Andersson, T., & Carlsson, S. (2012) · Diabetes Care · doi:10.2337/dc12-0913 · Cited by 58

New Era of Lipid-Lowering Drugs

Barter, P. J., & Rye, K. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012203 · Cited by 59

APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica

Ruiz-Narváez, E., Yang, Y., Nakanishi, Y., Kirchdorfer, J., & Campos, H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500040-jlr200 · Cited by 58

Serum apolipoprotein C‐III in high‐density lipoprotein: a key diabetogenic risk factor in Turks

Onat, A., Hergenç, G., Ayhan, E., Uğur, M., Kaya, H., Tuncer, M., & Can, G. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02814.x · Cited by 54

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

Poma, B. Z., Riva, A., Nasi, M., Cicconi, P., Broggini, V., Cozzi‐Lepri, A., Mologni, D., Mazzotta, F., Monforte, A. D., Mussini, C., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32830b3a96 · Cited by 54

Transcriptional Regulation of Apolipoprotein A5 Gene Expression by the Nuclear Receptor RORα

Genoux, A., Dehondt, H., Helleboid‐Chapman, A., Duhem, C., Hum, D. W., Martin, G., Pennacchio, L. A., Staels, B., Fruchart‐Najib, J., & Fruchart, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163841.85333.83 · Cited by 56

Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans

Pavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 53

Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and “insulin-resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction

Olivieri, O., Martinelli, N., Sandri, M., Bassi, A., Guarini, P., Trabetti, E., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.040477 · Cited by 50

Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population

Florez, H. J., Mendez, A. J., Casanova-Romero, P. Y., Larreal, C., Castillo-Florez, S., Lee, D. J., & Goldberg, R. B. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.013 · Cited by 46

Association between the -455T>C promoter polymorphism of the APOC3gene and the metabolic syndrome in a multi-ethnic sample

Pollex, R. L., Ban, M. R., Young, T. K., Bjerregaard, P., Anand, S. S., Yusuf, S., Zinman, B., Harris, S. B., Hanley, A. J., Connelly, P. W., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-80 · Cited by 48

ApoE ε2/ε3/ε4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome

Olivieri, O., Martinelli, N., Bassi, A., Trabetti, E., Girelli, D., Pizzolo, F., Friso, S., Pignatti, P. F., & Corrocher, R. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0142-y · Cited by 46

Joint Linkage and Association Analysis with Exome Sequence Data Implicates SLC25A40 in Hypertriglyceridemia

Rosenthal, E. A., Ranchalis, J., Crosslin, D. R., Burt, A., Brunzell, J. D., Motulsky, A. G., Nickerson, D. A., Wijsman, E. M., & Jarvik, G. P. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.019 · Cited by 42

The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets

Norwitz, N. G., Soto-Mota, A., Kaplan, B., Ludwig, D. S., Budoff, M. J., Kontush, A., & Feldman, D. (2022) · Metabolites · doi:10.3390/metabo12050460 · Cited by 41

Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study

Hosseini‐Esfahani, F., Mirmiran, P., DANESHPOUR, M. S., Mehrabi, Y., Hedayati, M., Soheilian‐Khorzoghi, M., & Azizi, F. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514003687 · Cited by 38

Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content

Peter, A., Kantartzis, K., Machicao, F. E., Machann, J., Wagner, S., Templin, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.154 · Cited by 37

Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk

Aroner, S. A., Yang, M., Li, J., Furtado, J. D., Sacks, F. M., Tjønneland, A. M., Overvad, K., Cai, T., & Jensen, M. K. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx143 · Cited by 34

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele

Olivieri, O., Martinelli, N., Baroni, M., Branchini, A., Girelli, D., Friso, S., Pizzolo, F., & Bernardi, F. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000440 · Cited by 32

Low High-Density Lipoprotein and Risk of Myocardial Infarction

Ramirez, A., & Hu, P. P. (2015) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s26624 · Cited by 31

Biological factors in plasma from diabetes mellitus patients enhance hyperglycaemia and pulsatile shear stress-induced endothelial cell apoptosis

Liu, X. F., Yu, J. Q., Dalan, R., Liu, A. Q., & Luo, K. Q. (2014) · Integrative Biology · doi:10.1039/c3ib40265g · Cited by 31

Lipid Biomarkers and Atherosclerosis—Old and New in Cardiovascular Risk in Childhood

Močnik, M., & Varda, N. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032237 · Cited by 30

The effect of melatonin on glucose tolerance, insulin sensitivity and lipid profiles after a late evening meal in healthy young males

Albreiki, M. S., Middleton, B., & Hampton, S. M. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12770 · Cited by 29

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study

Hopkins, P. N., Nanjee, M. N., Wu, L. L., McGinty, M. G., Brinton, E. A., Hunt, S. C., & Anderson, J. L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.016 · Cited by 29

Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia

Cruz‐Bautista, I., Mehta, R., Cabiedes, J., García-Ulloa, A. C., Guillén-Pineda, L. E., Almeda‐Valdés, P., Ramos, D. C., & Aguilar-Salinas, C. A. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.018 · Cited by 28

PROTEOMIC ANALYSIS OF RAT AORTA DURING ATHEROSCLEROSIS INDUCED BY HIGH CHOLESTEROL DIET AND INJECTION OF VITAMIN D3

Almofti, M. R., Huang, Z., Yang, P., Rui, Y., & Yang, P. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04366.x · Cited by 26

Additive effect of LRP8/APOER2 R952Q variant to APOE ε2/ε3/ε4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study

Martinelli, N., Olivieri, O., Shen, G.-Q., Trabetti, E., Pizzolo, F., Busti, F., Friso, S., Bassi, A., Li, L., Hu, Y., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-41 · Cited by 25

Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease

Lin, B., Huang, Y., Zhang, M., Wang, J., & Wu, Y. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004156 · Cited by 25

APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases

Zhang, R.-N., Zheng, R.-D., Mi, Y., Zhou, D., Shen, F., Chen, G., Zhu, C., Pan, Q., & Fan, J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4120-7 · Cited by 27

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials

Sahebkar, A., Simental‐Mendía, L. E., Mikhailidis, D. P., Pirro, M., Banach, M., Sirtori, C. R., Ruscica, M., & Reiner, Ž. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.008 · Cited by 25

ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression

Gerritsen, G., Rensen, P. C. N., Kypreos, K. E., Zannis, V. I., Havekes, L. M., & van Dijk, K. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400479-jlr200 · Cited by 24

Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis

Xu, C., Shu, S., Xia, C., PengXian, W., Sun, Y., Xu, C., & Li, C. (2015) · Veterinary Quarterly · doi:10.1080/01652176.2015.1055352 · Cited by 23

Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease

Martinelli, N., Girelli, D., Olivieri, O., Cavallari, U., Biscuola, M., Trabetti, E., Friso, S., Pizzolo, F., Tenuti, I., Bozzini, C., et al. (2005) · Clinical and Experimental Medicine · doi:10.1007/s10238-005-0060-9 · Cited by 22

Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status

Lamon‐Fava, S., Herrington, D. M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.012 · Cited by 22

Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks

Basavaraju, P., Balasubramani, R., Kathiresan, D. S., Devaraj, I., Babu, K., Vasanthakumar, A., & Moorthi, P. V. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.788852 · Cited by 22

Western Dietary Pattern Interaction with APOC3 Polymorphism in the Risk of Metabolic Syndrome: Tehran Lipid and Glucose Study

Hosseini‐Esfahani, F., Mirmiran, P., DANESHPOUR, M. S., Mehrabi, Y., Hedayati, M., Zarkesh, M., & Azizi, F. (2014) · Lifestyle Genomics · doi:10.1159/000365445 · Cited by 21

Consistency between cross-sectional and longitudinal SNP: blood lipid associations

Costanza, M. C., Beer‐Borst, S., James, R. W., Gaspoz, J., & Morabia, A. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9670-1 · Cited by 20

Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity

Baldi, S., Bonnet, F., Laville, M., Morgantini, C., Monti, L. D., Højlund, K., Ferrannini, E., Natali, A., & on behalf of the RISC Investigators (2013) · Diabetes Care · doi:10.2337/dc13-0682 · Cited by 20

Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction

Ruiz-Narváez, E., Sacks, F. M., & Campos, H. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1932 · Cited by 20

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy

Bonnet, É., Genoux, A., Bernard, J., Fauvel, J., Massip, P., & Perret, B. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.140 · Cited by 19

Impact of Type 1 Diabetes and Body Weight Status on Cardiovascular Risk Factors in Adolescent Children

Krishnan, S., Copeland, K. C., Bright, B. C., Gardner, A. W., Blackett, P. R., & Fields, D. A. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00395.x · Cited by 19

Graded Effects of Proteinuria on HDL Structure in Nephrotic Rats

Shearer, G. C., Newman, J. W. I., Hammock, B. D., & Kaysen, G. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080644 · Cited by 19

Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet

Lü, H., Lei, X., Guo, S., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01654-6 · Cited by 20

Military Community: A Privileged Site for Clinical Research: Epidemiological Study of Metabolic Syndrome Risk Factors in the Military Environment

Ceppa, F., Mérens, A., Burnat, P., Mayaudon, H., & Bauduceau, B. (2008) · Military Medicine · doi:10.7205/milmed.173.10.960 · Cited by 17

Review: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications

Sookoian, S. C., & Pirola, C. J. (2007) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707082702 · Cited by 16

Modulation of Pulmonary Toxicity in Metabolic Syndrome Due to Variations in Iron Oxide Nanoparticle-Biocorona Composition

Xia, L., Alqahtani, S., Ferreira, C. R., Aryal, U. K., Biggs, K., & Shannahan, J. H. (2022) · Nanomaterials · doi:10.3390/nano12122022 · Cited by 16

Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome

Kim, Y., Seo, H. S., Lee, E. M., Na, J. O., Choi, C. U., Lim, H. E., Kim, E. J., Rha, S., Park, C. G., & Oh, D. J. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.86 · Cited by 15

APOC3 482C>T polymorphism, circulating apolipoprotein C-III and smoking: Interrelation and roles in predicting type-2 diabetes and coronary disease

Onat, A., Erginel‐Ünaltuna, N., Çoban, N., Çiçek, G., & Yüksel, H. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.12.009 · Cited by 15

Clinical research Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndrome

Filippatos, T. D., Tsimihodimos, V., Kostapanos, M. S., Kostara, C. E., Bairaktari, E. T., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2008) · Cited by 14

Metabolic syndrome in children (Review)

Wu, Y., Zhang, C.-L., & Zhen, Q. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3632 · Cited by 16

Association of Apolipoproteins C3 and E with Metabolic Changes in HIV-Infected Adults Treated with a Protease-Inhibitor-Containing Antiretroviral Therapy

Bard, J., Lassalle, R., Capeau, J., Bach‐Ngohou, K., Nazih‐Sanderson, F., Rémy, G., Reynes, J., Ecobichon, J.-L., Savès, M., & Raffi, F. (2006) · Antiviral Therapy · doi:10.1177/135965350601100310 · Cited by 14

FXR crosstalk with other nuclear receptors

Mohammed, T. A., & Zalzala, M. H. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01118-2 · Cited by 14

Apolipoprotein C3 Gene Variants and Risk of Developing Type 2 Diabetes in Saudi Subjects

Alharbi, K. K., Hussain, T., Alharbi, F. K., Tabassum, S. N., Mohammed, A. A., Gambhir, D., & Khan, I. A. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0022 · Cited by 12

Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease

Pizzolo, F., Pavan, C., Guarini, P., Trabetti, E., Girelli, D., Corrocher, R., & Olivieri, O. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000187260.32567.75 · Cited by 12

Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease

Olivieri, O., Chiariello, C., Martinelli, N., Castagna, A., Speziali, G., Girelli, D., Pizzolo, F., Bassi, A., Cecconi, D., Robotti, E., et al. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1099 · Cited by 12

Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency

Garenc, C., Couillard, C., Laflamme, N., Cadelis, F., Gagné, C., Couture, P., Julien, P., & Bergeron, J. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201469 · Cited by 12

Characterization of the Metabolic Syndrome by Apolipoproteins in the Oklahoma Cherokee

Alaupovic, P., Blackett, P. R., Wang, W., & Lee, E. T. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00022.x · Cited by 11

Obesity: pathophysiology and treatment

Banning, M. (2005) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400512500408 · Cited by 11

Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics

Larach, D. B., Cuchel, M., & Rader, D. J. (2013) · Clinical Lipidology · doi:10.2217/clp.13.73 · Cited by 10

Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients

Clemente‐Postigo, M., Queipo‐Ortuño, M. I., Valdivielso, P., Tinahones, F. J., & Cardona, F. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.014 · Cited by 10

Transactivation of the human apical sodium-dependent bile acid transporter gene by human serum

Duane, W. C., Xiong, W., & Lofgren, J. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.07.005 · Cited by 10

Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)

Wybrańska, I., Malczewska-Malec, M., Partyka, Ł., Kieć‐Wilk, B., Kosno, K., Leszczynska-Golabek, I., Zdzienicka, A., Gruca, A., Kwaśniak, M., & Dembinska-Kiec, A. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.142 · Cited by 10

Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism

Luo, M., Su, X., Yi, Y., Yang, Y., & Peng, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0777-6 · Cited by 10

Metabolic syndrome in children and adolescents

Hong, Y. M. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.7.737 · Cited by 8

Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery

Bashir, B., Adam, S., Ho, J. H., Linn, Z., Durrington, P. N., & Soran, H. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000889 · Cited by 7

The Effect of APOC3 Promoter Polymorphisms on the Risk of Hypertriglyceridemia in Chinese Han Population With or Without Type 2 Diabetes Mellitus

Yu, J., Wang, H., Yang, S.-M., Yuan, J., Chen, L., Chen, C. L., Huang, D. F., Wang, Y., Ju, S.-Q., & ZHU, J.-Y. (2009) · Laboratory Medicine · doi:10.1309/lmubypdivgqwoy2u · Cited by 7

Homocysteine, traditional risk factors and impaired renal function in coronary artery disease

Pizzolo, F., Friso, S., Olivieri, O., Martinelli, N., Bozzini, C., Guarini, P., Trabetti, E., Faccini, G., Corrocher, R., & Girelli, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01714.x · Cited by 7

Effects of Leptin Receptor Gene 3'-untranslated Region Polymorphism on Metabolic Profiles in Young Japanese Men

Nishikai, K., Hirose, H., Ishii, T., Hayashi, M., Saito, I., & Saruta, T. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.73 · Cited by 4

ApoC-III gene polymorphisms and risk of coronary artery disease

Olivieri, O., Stranieri, C., Bassi, A., Zaia, B., Girelli, D., Pizzolo, F., Trabetti, E., Cheng, S., Grow, M. A., Pignatti, P. F., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200145-jlr200 · Cited by 70

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Onat, A., Hergenç, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., & Assmann, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00025-x · Cited by 134

"Linkage and Association Between Several Variants in the Apo CIII Gene Regions and risk of Coronary Artery Disease in Chinese Han Population"

Cui, W. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.35.005709

2MP01 The role of statin therapy in the prevention of coronary artery disease (CAD) in the diabetic

Steiner, G. A. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)90445-4

Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

Cui, F., Li, K., Li, Y., Zhang, X., & An, C. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-170 · Cited by 15